Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Merope Griffin
Chondroitin Sulfate Proteoglycan 4 and Its Potential as an Antibody Immunotherapy Target Across Different Tumor Types
Frontiers in Immunology
Allergy
Immunology
Related publications
Chondroitin Sulfate Proteoglycan (CSPG)
Science-Business eXchange
212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Histochemical Differentiation Between Chondroitin 4-Sulfate and Chondroitin 6-Sulfate.
Kurume Medical Journal
Medicine
Chondroitin Sulfate Proteoglycan 4 Specific Chimeric Antigen Receptor Therapy for Pediatric Solid Tumors
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Targeted Downregulation of N-Acetylgalactosamine 4-Sulfate 6-O-Sulfotransferase Significantly Mitigates Chondroitin Sulfate Proteoglycan-Mediated Inhibition
GLIA
Molecular Neuroscience
Neurology
Cellular
Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors
PLoS ONE
Multidisciplinary
Molecular Cloning of a Human Melanoma-Associated Chondroitin Sulfate Proteoglycan.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Frontiers in Immunology
Allergy
Immunology
Figure 4: Hearing Threshold Improvement Across Different Gorrie Types.
